Table 2.
Case number | Number of hotspots | Additional features on imaging | Palpable nodule | Previous surgery | Reason for referral | Histopathology | Treatment | Outcome | Long-term follow-up | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Neck | TI | Thorax | |||||||||
1 | 1 | 1 | Mediastinal 1 cm diameter ST opacity on XR | Yes | R then L UT 2 years apart | Recurrence of hyperthyroidism | ND | LD radioiodine | Euthyroid within 4 weeks post treatment | Still alive and euthyroid 4.5 years post treatment | |
2 | 1 | 2 | Yes | No | Owners interest in iodine treatment | ND | LD radioiodine | Euthyroid within 4 weeks post treatment | Lost to long-term follow-up | ||
3 | 2 | 1 | 2 | No | L then R UT | Recurrence of hyperthyroidism | ND | Carbimazole | Well controlled with medical management | Euthanased 5 months later with pancreatic neoplasia | |
4 | 2 | 1 | Yes | UT | Recurrence of hyperthyroidism, large palpable goitre | ND | Carbimazole | Well controlled with medical management | Euthanased 10 months later for unknown reason; euthyroid at time of euthanasia | ||
5 | 1 | 1 | 1 | Very large thoracic area of IRU | Yes | No | Difficulty medicating | ND | LD radioiodine | T4 reducing but not yet euthyroid after 4 weeks | Developed CHF, died 4 weeks post treatment |
6 | 1 | 1 | Mediastinal ST opacity on XR | No | UT | Carcinoma and concurrent disease | Carcinoma | No treatment | Severe concurrent cystitis and liver disease, euthanased at time of diagnosis | NA | |
7 | 1 | 1 | 2 | Yes | BT | Recurrence of hyperthyroidism | Adenoma | LD radioiodine | Remained hyperthyroid, successfully controlled with carbimazole treatment | Euthanased 2.5 years later with renal failure | |
8 | 2 | No | Yes | Recurrence of hyperthyroidism | ND | Carbimazole | Stabilised with medical management | Lost to follow-up | |||
9 | 1 | 1 | Yes | Yes | Recurrence of hyperthyroidism | Adenoma | Carbimazole | Stabilised with medical management | Lost to follow-up | ||
10 | 1 | No | Yes | Recurrence of hyperthyroidism | ND | Carbimazole | Stabilised with medical management | Lost to follow-up | |||
11 | 3 | 1 | 1 | On initial scintigraphy multiple areas of IRU in neck/TI/thorax, raising suspicions of carcinoma. Scintigraphy repeated after removal of further nodules for histopathology | No | UT 3 months previously, further thyroid nodules removed when hyper-thyroid-ism recurred | Recurrence of hyperthyroidism and suspicion of carcinoma | Adenoma | LD radioiodine | T4 significantly reduced 5 weeks post treatment but not yet euthyroid | Lost to follow-up |
12 | 2 | 1 | Clinician suspicious of carcinoma because of multiple areas of IRU | Yes | 2 L UT | Recurrence of hyperthyroidism | 2 Nodules removed – both adenoma | Methimazole | Well controlled with medical management | Developed laryngeal squamous cell carcinoma a few months later, time of euthanasia unknown | |
13 | 2 | Large area of IRU extending from inside thoracic inlet to heart base, clinician suspicious of carcinoma | Yes | UT 4 years previously | Persistence of hyperthyroidism following thyroidectomy | Adenoma | Surgical biopsy for histopathology, followed by LD radioiodine | Became hypothyroid; stabilised with thyroxine | Euthyroid (still on thyroxine) 2 years later then lost to further follow-up | ||
14 | 1 | No | No | Not recorded | ND | LD radioiodine | Unknown | Lost to follow-up | |||
15 | 2 | 1 | Extremely large area of IRU within mediastinum, connected to bilateral areas of IRU in neck | Yes | No | Owners interest in iodine treatment | ND | No apparent response to LD radioiodine, then treated with HD radioiodine | Euthyroid within 10 weeks post treatment | Lost to follow-up | |
16 | 1 | No | No | Poor response to methimazole | ND | LD radioiodine | Euthyroid within 4 weeks post treatment | Still alive and euthyroid 3 years post-treatment | |||
17 | 2 | 1 | 1 | Yes | No | Lack of response to LD radioiodine | ND, FNA suggestive of carcinoma | HD radioiodine | Euthyroid within 10 weeks post treatment, became hypothyroid | Still alive and hypothyroid (on thyroxine) 2.5 years later | |
18 | 2 | No | No | Poor response to methimazole and no palpable thyroid | ND | LD radioiodine | Euthyroid within 4 weeks post treatment | Still alive and euthyroid 21 months post treatment | |||
19 | 1 | No | 3 UT 1 year apart | Persistence of hyperthyroidism following 3rd thyroidectomy | ND | LD radioiodine | Euthyroid within 4 weeks post treatment | Still alive and euthyroid 27 months post treatment | |||
20 | 1 | Very large thoracic area of IRU | No | Yes | Recurrence of hyperthyroidism | ND, FNA suggestive of carcinoma | HD radioiodine | Died 2 weeks following treatment, cause unknown | NA | ||
21 | 1 | 1 | 1 | Widespread uptake of pertechnetate throughout pulmonary fields | Yes | UT | Treatment for carcinoma | Carcinoma | HD radioiodine | Euthyroid within 10 weeks post treatment | Remained euthyroid, euthanased 25 weeks post treatment due to pancytopenia (FIV positive) |
22 | 1 | 1 | 1 | Yes | UT | Difficulty medicating and owners interest in iodine treatment | ND | LD radioiodine | Euthyroid within 4 weeks post treatment | Lost to follow-up | |
23 | 1 | 1 | Yes | UT 8 months previously | Recurrence of hyperthyroidism and very large goitre led to suspicion of carcinoma | ND | LD radioiodine | T4 had reduced within 4 weeks post treatment but not euthyroid | 5 Months post treatment still not euthyroid but T4 continuing to decrease | ||
24 | 2 | 1 | 1 | Very extensive area IRU involving both glands in cervical area extending into cranial thorax cystic appearance on ultrasound | Yes | Yes | Poor response to medical treatment and large goitre suspicious of carcinoma | FNA suggestive of carcinoma, biopsy planned but died before performed | Methimazole | Euthanased due to development of CHF during investigations | NA |
25 | 2 | 1 | 1 | 1 Large area IRU involving both glands, down cervical region into thorax | Yes | No | Poor response to methimazole, large goitre | Adenomatous hyperplasia | LD radioiodine | No reduction in T4 | Stabilised more easily on lower dose methimazole compared with pre-iodine, despite no reduction in T4 with radioiodine alone. Alive and euthyroid 15 months post treatment |
26 | 1 | No | No | Difficulty medicating | ND | LD radioiodine | Euthyroid within 4 weeks post treatment | Still alive and euthyroid 7 months post treatment | |||
27 | 2 | 1 | Yes | No | Difficulty medicating | Adenomatous hyperplasia | Surgery | Euthyroid post surgery | Lost to follow-up |
R=right sided, L=left sided, ND=not done, FNA=fine needle aspirate, NA=not applicable.